Nkarta, Inc. (NKTX)

NASDAQ

$1.75

$-0.03

(-1.96%)

Pre-Market

Nkarta, Inc. (NKTX) Live Price Chart

Last updated: ⁦2026-10-20 12:59:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Nkarta, Inc. (NKTX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.75, with a market capitalization of $128.92M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.70 to $3.72. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$128.92M
Open	$1.79
Day's High	$79.16
Day's Low	$1.28
Previous Close	$1.75
Volume	2.62K
Average Volume	661.68K
P/E Ratio	--
52-Week High	$3.72
52-Week Low	$1.70
Dividend Yield	--
Earnings Date	--

Nkarta, Inc. (NKTX) Pre-Market Stock Price

Nkarta, Inc. (NKTX) is trading at $1.75 in pre-market trading as of 2026-10-20 12:52:00, unchanged from the previous close of $1.75

Pre-market trading shows how investors are pricing NKTX before the regular session opens. The current pre-market price is near the previous close, indicating neutral early trading sentiment.

Nkarta, Inc. (NKTX) 7-Day Stock Price Change

Over the past seven days, Nkarta, Inc. (NKTX) moved from $2.25 to $1.75, representing a decline of 22.22% ($0.50).

The stock traded between $1.75 and $2.31 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1.10 million shares, up versus the previous seven-day period, indicating higher trading activity.

NKTX 52-Week Price Position

Position in Range: 2.5%

52W Low$1.70

52W High$3.72

NKTX is currently trading at $1.75, placing it 2.5% of the way from its 52-week low of $1.70 to its 52-week high of $3.72. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Nkarta, Inc. (NKTX)?

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Nkarta, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	106
Exchange	NASDAQ
Company Website	https://www.nkartatx.com

How to Buy Nkarta, Inc. (NKTX) Stock on MEXC

Eligible investors can buy real shares of Nkarta, Inc. (NKTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for NKTX and Place Your Order

Open the RealStocks trading page and search for NKTX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Nkarta, Inc. (NKTX) stock price today?

Nkarta, Inc. (NKTX) is currently trading at $ 1.75, unchanged from the previous close of $ 1.75. Intraday prices update in real time during regular trading hours.

2.Is NKTX stock going up or down today?

As of 2026-10-20 12:52:00, NKTX is trading at $ 1.75, unchanged from its previous close of $ 1.75. The stock has traded between $ 1.28 and $ 79.16 during today’s regular session. Past price movements do not guarantee future results.

3.What is NKTX pre-market price?

As of 2026-10-20 12:52:00, NKTX is trading at $ 1.75 in pre-market trading, unchanged from the previous close of $ 1.75. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is NKTX after-hours price?

As of 2026-10-20 12:52:00, NKTX is trading at $ 1.79 in after-hours trading, up 2.00% ($0.03) from the regular-session close of $ 1.75. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is NKTX stock trading now?

NKTX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does NKTX sit relative to its 52-week high and low?

Over the past 52 weeks, NKTX has traded between a low of $ 1.70 and a high of $ 3.72. At $ 1.75, the stock is positioned 2.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Nkarta, Inc. in?

Nkarta, Inc. (NKTX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Nkarta, Inc.'s market capitalization and where is it listed?

Nkarta, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 128.92M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is NKTX valued in terms of P/E ratio and EPS?

NKTX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.65. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Nkarta, Inc. pay a dividend?

Nkarta, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.